NL140010B - Werkwijze voor het winnen van steriel, gesedimenteerd myxovirus uit het allantoisvocht van kippeeieren, waarin het virus is gekweekt. - Google Patents

Werkwijze voor het winnen van steriel, gesedimenteerd myxovirus uit het allantoisvocht van kippeeieren, waarin het virus is gekweekt.

Info

Publication number
NL140010B
NL140010B NL696904323A NL6904323A NL140010B NL 140010 B NL140010 B NL 140010B NL 696904323 A NL696904323 A NL 696904323A NL 6904323 A NL6904323 A NL 6904323A NL 140010 B NL140010 B NL 140010B
Authority
NL
Netherlands
Prior art keywords
silmented
allantois
myxovirus
virus
moisture
Prior art date
Application number
NL696904323A
Other languages
English (en)
Other versions
NL6904323A (nl
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL6904323A publication Critical patent/NL6904323A/xx
Publication of NL140010B publication Critical patent/NL140010B/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Indicating Or Recording The Presence, Absence, Or Direction Of Movement (AREA)
  • Measuring Volume Flow (AREA)
NL696904323A 1968-04-02 1969-03-20 Werkwijze voor het winnen van steriel, gesedimenteerd myxovirus uit het allantoisvocht van kippeeieren, waarin het virus is gekweekt. NL140010B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71819068A 1968-04-02 1968-04-02

Publications (2)

Publication Number Publication Date
NL6904323A NL6904323A (nl) 1969-10-06
NL140010B true NL140010B (nl) 1973-10-15

Family

ID=24885166

Family Applications (1)

Application Number Title Priority Date Filing Date
NL696904323A NL140010B (nl) 1968-04-02 1969-03-20 Werkwijze voor het winnen van steriel, gesedimenteerd myxovirus uit het allantoisvocht van kippeeieren, waarin het virus is gekweekt.

Country Status (14)

Country Link
US (1) US3514374A (nl)
JP (1) JPS5550008B1 (nl)
BE (1) BE730802A (nl)
CH (1) CH510116A (nl)
DK (1) DK121456B (nl)
ES (1) ES365398A1 (nl)
FI (1) FI45864C (nl)
FR (1) FR2007367A1 (nl)
GB (1) GB1212952A (nl)
IE (1) IE33019B1 (nl)
IL (1) IL31888A (nl)
NL (1) NL140010B (nl)
NO (1) NO125937B (nl)
SE (1) SE360381B (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880993A (en) * 1972-12-04 1975-04-29 Inst Microbiologie Et D Hygien Process for the filtration of a suspension containing a protein such as an influenza virus vaccine
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
US4327182A (en) * 1981-01-22 1982-04-27 Connaught Laboratories Incorporated Purification of influenza sub-unit vaccine
ES2000034A6 (es) * 1985-11-26 1987-10-01 Schweiz Serum & Impfinst Procedimiento para la preparacion de una vacuna viva contra paperas
DE4422238C2 (de) * 1994-06-24 1996-05-30 Behringwerke Ag Verfahren zur Isolierung einer Antigenpräparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2355676A (en) * 1941-03-07 1944-08-15 Squibb & Sons Inc Lymphogranuloma venereum antigen and method of preparing it
US2854143A (en) * 1957-02-13 1958-09-30 Ohio Commw Eng Co Centrifugal stratifier with plural filter means

Also Published As

Publication number Publication date
FI45864B (nl) 1972-06-30
FR2007367A1 (nl) 1970-01-09
IE33019B1 (en) 1974-02-20
ES365398A1 (es) 1971-01-01
IL31888A0 (en) 1969-05-28
NO125937B (nl) 1972-11-27
GB1212952A (en) 1970-11-18
IE33019L (en) 1969-10-02
JPS5550008B1 (nl) 1980-12-16
FI45864C (fi) 1972-10-10
SE360381B (nl) 1973-09-24
IL31888A (en) 1972-08-30
NL6904323A (nl) 1969-10-06
BE730802A (nl) 1969-09-30
US3514374A (en) 1970-05-26
DK121456B (da) 1971-10-18
CH510116A (de) 1971-07-15

Similar Documents

Publication Publication Date Title
NL152576B (nl) Werkwijze voor de bereiding van gemodificeerde organopolysiloxanen.
NL159099B (nl) Werkwijze voor het bereiden van gezuiverd glycolide of lactide.
NL163768C (nl) Werkwijze voor de bereiding van racemische of optisch actieve 3,3-dimethyl-2-gesubstitueerde-cyclopropaan- -1-carbonzuren met cis-structuur.
NL141363B (nl) Werkwijze voor de bereiding van kunstmatig vlees.
NL158521B (nl) Werkwijze voor de bereiding van polypentenameren met overwegend transstructuur.
NL150663B (nl) Werkwijze voor het aromatiseren van voedingsmiddelen.
NL167470C (nl) Werkwijze voor de bereiding van s-adenosyl-l-methionine of s-adenosyl-l-ethionine.
NL148105B (nl) Werkwijze voor het winnen van proteinen uit bacterien en gevormde voorwerpen, vervaardigd uit deze proteinen.
NL141839B (nl) Werkwijze voor de bereiding van titaancarbide.
NL155175B (nl) Inrichting voor het plukken van gevogelte.
NL146028B (nl) Inrichting voor het verwijderen van het bot uit een stuk dierlijk vlees.
NL140010B (nl) Werkwijze voor het winnen van steriel, gesedimenteerd myxovirus uit het allantoisvocht van kippeeieren, waarin het virus is gekweekt.
NL148223B (nl) Werkwijze voor het bereiden van kattenvoer.
NL142573B (nl) Inrichting voor het verwijderen van het metatarsus-voetgedeelte en de achillespees uit de poot van gevogelte.
NL156160B (nl) Werkwijze voor het bereiden van macromoleculaire polyimiden, alsmede gevormd voortbrengsel, geheel of gedeeltelijk bestaande uit de aldus verkregen polyimiden.
NL170753B (nl) Werkwijze voor het winnen van glycerolkinase uit micro-organismen.
NL150157B (nl) Werkwijze voor de bereiding van preparaten uit met vulstof gemengde polymeren.
NL158499B (nl) Werkwijze voor de bereiding van tetramethylorthosilicaat.
NL169871C (nl) Werkwijze voor de bereiding van p-nitrosofenolen en p-nitrofenolen.
NL161423C (nl) Werkwijze voor de bereiding van plantenvoedingsbodem.
NL155006B (nl) Werkwijze voor de bereiding van beta-ionon.
NL7411996A (nl) Werkwijze voor het verwijderen van lood uit molybdeniet.
NL162544C (nl) Inrichting voor het verwijderen van het bot uit een stuk dierlijk vlees.
NL163764C (nl) Werkwijze voor het bereiden van alkanonen uit olefinen.
NL161163C (nl) Werkwijze voor de bereiding van hydroxyalkylaminoalkaan- fosfonaten.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: MERCK